Comparison Between Home-based Wearable Device and Supervised PFMT on SUI/MUI

  • STATUS
    Recruiting
  • End date
    May 1, 2023
  • participants needed
    500
  • sponsor
    Peking Union Medical College Hospital
Updated on 5 May 2022

Summary

Objective The study is designed to compare the benefit of self-assessment of a home-based wearable device assisted pelvic floor muscle training (PFMT) to standard supervised PMFT program for women with SUI/MUI (stress urinary incontinence/mixed urinary incontinence).

Background National and international clinical practice guidelines recommend supervised pelvic floor muscle training of at least 3 months' duration as a first-line treatment to women (including the elderly and post-natal) with stress or mixed urinary incontinence (Level of evidence A). However, it remains unknown that which component could bring extra benefit when assisted with surprised PFMT.

Patients selection and study design The study protocol was approved by the Peking union medical college hospital ethics committee (JS-3192D, 26/10/2021). Women who had their 6-week to 3-month postpartum clinical visits in the member hospitals between Dec 01, 2021 and May 01, 2022 were invited to participate in the study. The women who reported SUI/MUI symptoms within 3 months postpartum were recruited. The exclusion criteria were 1)urgency urinary incontinence alone; 2)a prolapse greater than stage II on examination (>1cm below the hymen on straining); 3)third and fourth degree perineal tear; 4)suffering diastasis recti abdominis and chronic pelvic pain as the primary problem need treatment; 5)a history of stress urinary incontinence(SUI) before pregnancy; 6)had previous pelvic surgery; 7)malignant pelvic cancer; 8)Genurological infection; 9)had received formal instruction on PFMT in the past 5 years; 10)unsuitable to participate because of significant diseases; 11)others:were unable to contract pelvic floor muscles on digital examination when requested;Inability to use the device in vagina. Once each participate was recruited, they were arranged randomly to either an intervention group or a control group (1:1). The intervention group used a wireless wearable vaginal device to record the pressure and practice time and the grade of type I and II pelvic floor muscle fiber strength were assessed by the device once three weeks. The control group accepted the supervised PFMT. Both groups followed the same program three months. During three months, the investigators phoned both groups once three weeks to guide their training. Both groups were assessed by questionnaire and PFM measurements at baseline(pre-test), 3-month, 6-month and 12-month. The primary outcome is ICIQ-UI SF; The secondary outcomes include POP-SS; POP-Q; Oxford Classification; Pelvic floor muscle surface electromyography; I-QOL; PISQ-12; BPMSES.

The hypothesis is that the wearable device with self-assessment function providing PFMT is superior to the supervised PFMT program alone for the treatment of both SUI and MUI of postpartum women.

Details
Condition Stress Urinary Incontinence
Treatment PFMT with device
Clinical Study IdentifierNCT05115864
SponsorPeking Union Medical College Hospital
Last Modified on5 May 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

weeks<After delivery<3 mo postpartum
Clinically diagnosed stress or mixed urinary incontinence as the primary problem
Women aged 18 years or older

Exclusion Criteria

Urgency urinary incontinence alone
A prolapse greater than stage II on examination (>1cm below the hymen on straining)
Third and fourth degree perineal tear
Suffering diastasis recti abdominis and chronic pelvic pain as the primary problem need treatment
A history of stress urinary incontinence (SUI) before pregnancy
Had previous pelvic surgery
Malignant pelvic cancer
Genitourinary system infection
Had received formal instruction on PFMT in the past 5 years
Unsuitable to participate because of significant diseases
Others: were unable to contract pelvic floor muscles on digital examination when requested; Inability to use the device in vagina
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note